Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:FSNUY
- CUSIP: N/A
- Web: www.fresenius.com
- 52 Week Range: $17.22 - $22.30
Sales & Book Value:
- Trailing P/E Ratio: 22.16
- Foreward P/E Ratio: 5.05
- P/E Growth: 0.00
- Annual Revenue: $37.35 billion
- Price / Sales: N/A
- Book Value: $6.94 per share
- Price / Book: 3.00
Frequently Asked Questions for Fresenius SE (NASDAQ:FSNUY)
What is Fresenius SE's stock symbol?
Fresenius SE trades on the NASDAQ under the ticker symbol "FSNUY."
How often does Fresenius SE pay dividends? What is the dividend yield for Fresenius SE?
Fresenius SE declared a None dividend on Thursday, June 29th. Shareholders of record on Wednesday, May 17th will be paid a dividend of $0.112 per share on Wednesday, May 24th. The ex-dividend date is Monday, May 15th. View Fresenius SE's Dividend History.
When will Fresenius SE make its next earnings announcement?
Who are some of Fresenius SE's key competitors?
Some companies that are related to Fresenius SE include Abbott Laboratories (ABT), Eli Lilly and Company (LLY), Allergan PLC. (AGN), Astrazeneca PLC (AZN), Stryker Corporation (SYK), Anthem (ANTM), Regeneron Pharmaceuticals (REGN), Becton, Dickinson and Company (BDX), Shire PLC (SHPG), Takeda Pharmaceutical (TKPYY), Vertex Pharmaceuticals Incorporated (VRTX), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Humana (HUM), Express Scripts Holding Company (ESRX), McKesson Corporation (MCK), Actelion (ALIOF) and Fresenius Medical Care Corporation (FMS).
How do I buy Fresenius SE stock?
Shares of Fresenius SE can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fresenius SE's stock price today?
MarketBeat Community Rating for Fresenius SE (NASDAQ FSNUY)MarketBeat's community ratings are surveys of what our community members think about Fresenius SE and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Fresenius SE stock can currently be purchased for approximately $20.79.
Consensus Ratings for Fresenius SE (NASDAQ:FSNUY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Fresenius SE (NASDAQ:FSNUY)
(Data available from 8/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|4/11/2016||Sanford C. Bernstein||Initiated Coverage||Outperform||N/A|
|2/12/2016||Berenberg Bank||Upgrade||Hold -> Buy||N/A|
Earnings History for Fresenius SE (NASDAQ:FSNUY)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Fresenius SE (NASDAQ:FSNUY)
Current Year EPS Consensus Estimate: $3.69 EPS
Next Year EPS Consensus Estimate: $4.12 EPS
Dividend History by Quarter for Fresenius SE (NASDAQ FSNUY)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Fresenius SE (NASDAQ:FSNUY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Fresenius SE (NASDAQ:FSNUY)
Latest Headlines for Fresenius SE (NASDAQ:FSNUY)
Fresenius SE (FSNUY) Chart for Wednesday, August, 23, 2017